These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 21124982)
21. Patenting nanotechnology. Lemley MA Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838 [TBL] [Abstract][Full Text] [Related]
22. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act. Colaianni A; Cook-Deegan R Milbank Q; 2009 Sep; 87(3):683-715. PubMed ID: 19751286 [TBL] [Abstract][Full Text] [Related]
23. Patent first, ask questions later: morality and biotechnology in patent law. Bagley MA William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677 [TBL] [Abstract][Full Text] [Related]
24. Biotechnological Patents Applications of the Deuterium Oxide in Human Health. da S Mariano RM; Bila WC; Trindade MJF; Lamounier JA; Galdino AS Recent Pat Biotechnol; 2017; 11(2):76-84. PubMed ID: 28078979 [TBL] [Abstract][Full Text] [Related]
25. Analysis of patent innovation in the field of brachytherapy. Miljanic M; Prabhu AV; Patel M; Lewis GD; Kim T Brachytherapy; 2020; 19(4):510-517. PubMed ID: 32249181 [TBL] [Abstract][Full Text] [Related]
26. An examination of nurse-authored patents: Implications for nursing practice. Davis CR; Glasgow MES Nurs Forum; 2020 Nov; 55(4):772-781. PubMed ID: 32851679 [TBL] [Abstract][Full Text] [Related]
27. Patent and license pearls and pitfalls for taking an idea to the marketplace. Mukharji I J Investig Med; 2011 Jun; 59(5):758-61. PubMed ID: 21441827 [TBL] [Abstract][Full Text] [Related]
28. Ethical questions to ponder in the European stem cell patent debate. Curley D; Sharples A J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135 [TBL] [Abstract][Full Text] [Related]
29. How can you patent genes? Eisenberg RS Am J Bioeth; 2002; 2(3):3-11. PubMed ID: 12230840 [TBL] [Abstract][Full Text] [Related]
31. Trends in the human embryonic stem cell patent field. Karlsson U; Hyllner J; Runeberg K Recent Pat Nanotechnol; 2007; 1(3):233-7. PubMed ID: 19076035 [TBL] [Abstract][Full Text] [Related]
32. The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology. Gold ER; Caulfield TA Lancet; 2002 Jun; 359(9325):2268-70. PubMed ID: 12103305 [TBL] [Abstract][Full Text] [Related]
33. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property]. Jannuzzi AH; Vasconcellos AG; de Souza CG Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747 [TBL] [Abstract][Full Text] [Related]
34. Citations in Life Science Patents to Publicly Funded Research at Academic Medical Centers. Sampat BN; Pincus HA Clin Transl Sci; 2015 Dec; 8(6):759-63. PubMed ID: 26728947 [TBL] [Abstract][Full Text] [Related]
35. [Biotechnology research and generation of patents of interest to the health system]. Plaza Gómez L; Albert Martínez A Med Clin (Barc); 2008 Dec; 131 Suppl 5():55-9. PubMed ID: 19631824 [TBL] [Abstract][Full Text] [Related]
36. Strategies for stem cell patent applications in the light of recent court cases. Eyre DE; Schlich GW Pharm Pat Anal; 2015; 4(6):431-41. PubMed ID: 26580992 [TBL] [Abstract][Full Text] [Related]
37. Innovations and intellectual property: the case of genomic patenting. Jackson BA J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760 [TBL] [Abstract][Full Text] [Related]